Vimarsana
Biggest News Aggregation in the World

Page 2 - Spirovant Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Spirovant Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Spirovant Sciences Today - Breaking & Trending Today

Spirovant Launches State-of-the-Art Laboratory and Headquarters - Vimarsana News

Spirovant Launches State-of-the-Art Laboratory and Headquarters

/PRNewswire/ -- Spirovant Sciences, a gene therapy company developing treatments for respiratory diseases, including cystic fibrosis (CF), announced today the...

Science Center Appoints New Vice President of Real Estate - Vimarsana News

Science Center Appoints New Vice President of Real Estate

PHILADELPHIA, PA -- (March 2, 2022) – The University City Science Center has welcomed Timnit Abraha as Vice President, Real Estate. Ms. Abraha joins the organization following the retirement of its long-time Senior Vice President of Real Estate Curt Hess.

Myovant Sciences Announces Preliminary Financial Results for Third Quarter of Fiscal Year 2021 - Vimarsana News

Myovant Sciences Announces Preliminary Financial Results for Third Quarter of Fiscal Year 2021

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Source: apnews.com
Sumitovant Biopharma Highlights Significant Clinical, Regulatory and Commercial Achievements Across its Portfolio of Companies in the Second Quarter of FY2021 - Vimarsana News

Sumitovant Biopharma Highlights Significant Clinical, Regulatory and Commercial Achievements Across its Portfolio of Companies in the Second Quarter of FY2021

/PRNewswire/ -- Sumitovant Biopharma, Inc. today announced that its portfolio of four wholly-owned subsidiary companies (Urovant, Enzyvant, Altavant and...

Sumitovant Biopharma Highlights Significant Clinical, Regulatory and Commercial Achievements Across its Portfolio of Companies in the Second Quarter of FY2021 - Vimarsana News

Sumitovant Biopharma Highlights Significant Clinical, Regulatory and Commercial Achievements Across its Portfolio of Companies in the Second Quarter of FY2021

/PRNewswire/ -- Sumitovant Biopharma, Inc. today announced that its portfolio of four wholly-owned subsidiary companies (Urovant, Enzyvant, Altavant and...